Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 8/2016

01-08-2016 | Original Article

Long-noncoding RNAs in basal cell carcinoma

Authors: Michael Sand, Falk G. Bechara, Daniel Sand, Thilo Gambichler, Stephan A. Hahn, Michael Bromba, Eggert Stockfleth, Schapoor Hessam

Published in: Tumor Biology | Issue 8/2016

Login to get access

Abstract

Long noncoding RNAs (lncRNAs) are fundamental regulators of pre- and post-transcriptional gene regulation. Over 35,000 different lncRNAs have been described with some of them being involved in cancer formation. The present study was initiated to describe differentially expressed lncRNAs in basal cell carcinoma (BCC). Patients with BCC (n = 6) were included in this study. Punch biopsies were harvested from the tumor center and nonlesional epidermal skin (NLES, control, n = 6). Microarray-based lncRNA and mRNA expression profiles were identified through screening for 30,586 lncRNAs and 26,109 protein-coding transcripts (mRNAs). The microarray data were validated by RT-PCR in a second set of BCC versus control samples. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses of mRNAs were performed to assess biologically relevant pathways. A total of 1851 lncRNAs were identified as being significantly up-regulated, whereas 2165 lncRNAs were identified as being significantly down-regulated compared to nonlesional skin (p < 0.05). Oncogenic and/or epidermis-specific lncRNAs, such as CASC15 or ANRIL, were among the differentially expressed sequences. GO analysis showed that the highest enriched GO targeted by up-regulated transcripts was “extracellular matrix.” KEGG pathway analysis showed the highest enrichment scores in “Focal adhesion.” BCC showed a significantly altered lncRNA and mRNA expression profile. Dysregulation of previously described lncRNAs may play a role in the molecular pathogenesis of BCC and should be subject of further analysis.
Appendix
Available only for authorised users
Literature
1.
2.
3.
Sand M, Gambichler T, Sand D, Skrygan M, Altmeyer P, Bechara FG. MicroRNAs and the skin: tiny players in the body’s largest organ. J Dermatol Sci. 2009;53:169–75.CrossRefPubMed
4.
Sand M, Skrygan M, Sand D, Georgas D, Hahn SA, Gambichler T, et al. Expression of microRNAs in basal cell carcinoma. Br J Dermatol. 2012;167:847–55.CrossRefPubMed
5.
Sand M, Gambichler T, Skrygan M, Sand D, Scola N, Altmeyer P, et al. Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer. Cancer Investig. 2010;28:649–53.CrossRef
6.
Sand M, Skrygan M, Georgas D, Arenz C, Gambichler T, Sand D, et al. Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer. Mol Carcinog. 2012;51:916–22.CrossRefPubMed
7.
Sand M, Sand D, Altmeyer P, Bechara FG. MicroRNA in non-melanoma skin cancer. Cancer Biomarkers : Sect Dis Markers. 2012;11:253–7.CrossRef
8.
Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22:1775–89.CrossRefPubMedPubMedCentral
9.
Guo X, Gao L, Wang Y, Chiu DK, Wang T, Deng Y et al. Advances in long noncoding rnas: Identification, structure prediction and function annotation. Brief Funct Genomics 2015, in press
10.
Hombach S, Kretz M. The non-coding skin: exploring the roles of long non-coding RNAs in epidermal homeostasis and disease. Bioessays. 2013;35:1093–100.CrossRefPubMed
11.
Ezkurdia I, Juan D, Rodriguez JM, Frankish A, Diekhans M, Harrow J, et al. Multiple evidence strands suggest that there may be as few as 19 000 human protein-coding genes. Hum Mol Genet. 2014;23:5866–78.CrossRefPubMedPubMedCentral
12.
Li X, Wu Z, Fu X, Han W. LncRNAs: insights into their function and mechanics in underlying disorders. Mutat Res Rev Mutat Res. 2014;762:1–21.CrossRefPubMed
13.
14.
Kretz M, Webster DE, Flockhart RJ, Lee CS, Zehnder A, Lopez-Pajares V, et al. Suppression of progenitor differentiation requires the long noncoding RNA ANCR. Genes Dev. 2012;26:338–43.CrossRefPubMedPubMedCentral
15.
Lopez-Pajares V, Qu K, Zhang J, Webster DE, Barajas BC, Siprashvili Z, et al. A LncRNA-MAF:MAFB transcription factor network regulates epidermal differentiation. Dev Cell. 2015;32:693–706.CrossRefPubMedPubMedCentral
16.
Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, et al. Long noncoding RNAs with enhancer-like function in human cells. Cell. 2010;143:46–58.CrossRefPubMedPubMedCentral
17.
Mazar J, Sinha S, Dinger ME, Mattick JS, Perera RJ. Protein-coding and non-coding gene expression analysis in differentiating human keratinocytes using a three-dimensional epidermal equivalent. Mol Genet Genomics : MGG. 2010;284:1–9.CrossRefPubMed
18.
19.
Hajjari M, Khoshnevisan A, Shin YK. Molecular function and regulation of long non-coding RNAs: paradigms with potential roles in cancer. Tumour Biol. 2014;35:10645–63.CrossRefPubMed
20.
Hsu F, Kent WJ, Clawson H, Kuhn RM, Diekhans M, Haussler D. The UCSC known genes. Bioinformatics. 2006;22:1036–46.CrossRefPubMed
21.
Harrow J, Denoeud F, Frankish A, Reymond A, Chen CK, Chrast J, et al. GENCODE: producing a reference annotation for encode. Genome Biol. 2006;7(1):1–9. S4.CrossRef
22.
Pang KC, Stephen S, Dinger ME, Engstrom PG, Lenhard B, Mattick JS. RNAdb 2.0-—an expanded database of mammalian non-coding RNAs. Nucleic Acids Res. 2007;35:D178–82.CrossRefPubMed
23.
Dinger ME, Pang KC, Mercer TR, Crowe ML, Grimmond SM, Mattick JS. NRED: a database of long noncoding RNA expression. Nucleic Acids Res. 2009;37:D122–6.CrossRefPubMed
24.
Amaral PP, Clark MB, Gascoigne DK, Dinger ME, Mattick JS. LncRNAdb: A reference database for long noncoding RNAs. Nucleic Acids Res. 2011;39:D146–51.CrossRefPubMed
25.
Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A. 2009;106:11667–72.CrossRefPubMedPubMedCentral
26.
Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A, et al. Integrative annotation of human large intergenic noncodingRNA reveals global properties and specific subclasses. Genes Dev. 2011;25:1915–27.CrossRefPubMedPubMedCentral
27.
Bejerano G, Pheasant M, Makunin I, Stephen S, Kent WJ, Mattick JS, et al. Ultraconserved elements in the human genome. Science. 2004;304:1321–5.CrossRefPubMed
28.
Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007;129:1311–23.CrossRefPubMedPubMedCentral
29.
Luo X, Shi Q, Gu Y, Pan J, Hua M, Liu M, et al. LncRNA pathway involved in premature preterm rupture of membrane (PPROM): an epigenomic approach to study the pathogenesis of reproductive disorders. PLoS One. 2013;8, e79897.CrossRefPubMedPubMedCentral
30.
Gene Ontology C. Gene ontology consortium: going forward. Nucleic Acids Res. 2015;43:D1049–56.CrossRef
31.
Consortium TGO. Gene ontology consortium: going forward. Nucleic Acids Res. 2015;43:D1049–56.CrossRef
32.
Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001;125:279–84.CrossRefPubMed
33.
34.
Sokal RR, Michener CD. A statistical method for evaluating systematic relationships. Univ Kansas Sci Bull. 1958;28:1409–38.
35.
Gene Ontology C. The gene ontology project in 2008. Nucleic Acids Res. 2008;36:D440–4.CrossRef
36.
Gene Ontology C. The gene ontology in 2010: extensions and refinements. Nucleic Acids Res. 2010;38:D331–5.CrossRef
37.
Xing Z, Lin A, Li C, Liang K, Wang S, Liu Y, et al. LncRNA directs cooperative epigenetic regulation downstream of chemokine signals. Cell. 2014;159:1110–25.CrossRefPubMedPubMedCentral
38.
39.
40.
Wang Y, Chen W, Chen J, Pan Q, Pan J. LncRNA expression profiles of EGFR exon 19 deletions in lung adenocarcinoma ascertained by using microarray analysis. Med Oncol. 2014;31:137.CrossRefPubMed
41.
Chen X. Predicting lncRNA-disease associations and constructing lncRNA functional similarity network based on the information of miRNA. Sci Rep. 2015;5:13186.CrossRefPubMedPubMedCentral
42.
Zhuang M, Gao W, Xu J, Wang P, Shu Y. The long non-coding RNA h19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1. Biochem Biophys Res Commun. 2014;448:315–22.CrossRefPubMed
43.
Li H, Yu B, Li J, Su L, Yan M, Zhu Z, et al. Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget. 2014;5:2318–29.CrossRefPubMedPubMedCentral
44.
Wang X, El Naqa IM. Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics. 2008;24:325–32.CrossRefPubMed
45.
Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM, et al. MicroRNAs in the miR-106b family regulate p21/CDKN1a and promote cell cycle progression. Mol Cell Biol. 2008;28:2167–74.CrossRefPubMedPubMedCentral
46.
Russell MR, Penikis A, Oldridge DA, Alvarez-Dominguez JR, McDaniel L, Diamond M, et al. CASC15-s is a tumor suppressor lncRNA at the 6p22 neuroblastoma susceptibility locus. Cancer Res. 2015;75:3155–66.CrossRefPubMedPubMedCentral
47.
Lessard L, Liu M, Marzese DM, Wang H, Chong K, Kawas N et al. The casc15 long intergenic noncoding rna locus is involved in melanoma progression and phenotype switching. J Invest Dermatol 2015;135(10):2464–74.
48.
Rabinowitz YS, Dong L, Wistow G. Gene expression profile studies of human keratoconus cornea for NEIBank: a novel cornea-expressed gene and the absence of transcripts for aquaporin 5. Invest Ophthalmol Vis Sci. 2005;46:1239–46.CrossRefPubMed
49.
Naemura M, Murasaki C, Inoue Y, Okamoto H, Kotake Y. Long noncoding RNA ANRIL regulates proliferation of non-small cell lung cancer and cervical cancer cells. Anticancer Res. 2015;35:5377–82.PubMed
50.
Iranpour M, Soudyab M, Geranpayeh L, Mirfakhraie R, Azargashb E, Movafagh A et al. Expression analysis of four long noncoding rnas in breast cancer. Tumour Biol 2015, in press
51.
Kretz M, Siprashvili Z, Chu C, Webster DE, Zehnder A, Qu K, et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature. 2013;493:231–5.CrossRefPubMed
52.
Wan DC, Wang KC. Long noncoding RNA: significance and potential in skin biology. Cold Spring Harb Perspect Med. 2014;4.
53.
54.
Szegedi K, Sonkoly E, Nagy N, Nemeth IB, Bata-Csorgo Z, Kemeny L, et al. The anti-apoptotic protein G1P3 is overexpressed in psoriasis and regulated by the non-coding RNA, PRINS. Exp Dermatol. 2010;19:269–78.CrossRefPubMed
55.
Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature. 2011;472:120–4.CrossRefPubMedPubMedCentral
56.
Jiang YJ, Bikle DD. LncRNA profiling reveals new mechanism for VDR protection against skin cancer formation. J Steroid Biochem Mol Biol. 2014;144(Pt A):87–90.PubMed
Metadata
Title
Long-noncoding RNAs in basal cell carcinoma
Authors
Michael Sand
Falk G. Bechara
Daniel Sand
Thilo Gambichler
Stephan A. Hahn
Michael Bromba
Eggert Stockfleth
Schapoor Hessam
Publication date
01-08-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 8/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-016-4927-z

Other articles of this Issue 8/2016

Tumor Biology 8/2016 Go to the issue

Original Article

The effect of antisense inhibitor of miRNA 106b∼25 on the proliferation, invasion, migration, and apoptosis of gastric cancer cell

Original Article

Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expression

Original Article

Complete loss of STAG2 expression is an indicator of good prognosis in patients with bladder cancer

Original Article

RETRACTED ARTICLE: miR-152 functions as a tumor suppressor in colorectal cancer by targeting PIK3R3

Original Article

Clinical impact of circulating microRNAs as blood-based marker in childhood acute lymphoblastic leukemia

Original Article

The potential role of CacyBP/SIP in tumorigenesis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits